Story
Typcal is brewing the future of pragmatic protein
While the food industry grapples with the compromises of plant-based alternatives and the distant promise of lab-grown meat, a Brazilian scaleup is brewing a practical solution.
A biotech company specializing in treatments for neurodegenerative diseases needed a press release to announce promising research findings.
The goal was to craft a professional and impactful press release that captured the significance of the discovery and resonated with both national and international audiences, driving widespread media coverage.
The news received extensive media coverage, appearing in national newspapers, regional TV, and international industry publications. This wide-ranging attention significantly boosted the company’s visibility and reinforced its position as a leader in innovative drug discovery for neurodegenerative diseases.
While the food industry grapples with the compromises of plant-based alternatives and the distant promise of lab-grown meat, a Brazilian scaleup is brewing a practical solution.
Julie van der Zee (VIB-UAntwerp Center for Molecular Neuroscience) on biobanking, trust, and the long road from discovery to intervention.
Giovanni Maglia reflects on the future of next-generation proteomics and the challenges of de novo protein sequencing.
Get notified about new articles, Tips & tricks and other opportunities.
